Compare CK-MB mass immunoassay to total CK activity testing, including their clinical implications.

Prepare for the Clinical Chemistry and Pathologic of Biochemistry Exam with comprehensive questions, detailed explanations, and effective study strategies. Ace your test with confidence!

Multiple Choice

Compare CK-MB mass immunoassay to total CK activity testing, including their clinical implications.

CK-MB mass immunoassay and total CK activity test tap into different aspects of creatine kinase biology. CK has three isoenzymes: CK-MM (mostly in skeletal muscle), CK-MB (primarily in heart muscle but present in small amounts in skeletal muscle), and CK-BB (brain). The total CK activity assay measures the combined enzymatic activity of all isoenzymes, so a rise can result from skeletal muscle injury, strenuous exercise, or muscle diseases in addition to heart injury. This makes total CK activity less specific for myocardial injury because it reflects the overall CK pool, not just the heart-derived fraction. The CK-MB mass immunoassay, on the other hand, quantifies the CK-MB protein specifically with antibodies. Since CK-MB is enriched in myocardium, its presence is a more direct marker of heart muscle injury. Clinically, this means CK-MB mass is better at indicating myocardial injury than total CK activity, which is more influenced by non-cardiac muscle sources. Of course, CK-MB is not perfect, and troponin assays offer even higher specificity and sensitivity for myocardial injury, but among these two tests, CK-MB mass provides greater specificity for cardiac damage because it targets the relevant isoenzyme rather than the total enzyme activity originating from multiple tissues.

CK-MB mass immunoassay and total CK activity test tap into different aspects of creatine kinase biology. CK has three isoenzymes: CK-MM (mostly in skeletal muscle), CK-MB (primarily in heart muscle but present in small amounts in skeletal muscle), and CK-BB (brain). The total CK activity assay measures the combined enzymatic activity of all isoenzymes, so a rise can result from skeletal muscle injury, strenuous exercise, or muscle diseases in addition to heart injury. This makes total CK activity less specific for myocardial injury because it reflects the overall CK pool, not just the heart-derived fraction.

The CK-MB mass immunoassay, on the other hand, quantifies the CK-MB protein specifically with antibodies. Since CK-MB is enriched in myocardium, its presence is a more direct marker of heart muscle injury. Clinically, this means CK-MB mass is better at indicating myocardial injury than total CK activity, which is more influenced by non-cardiac muscle sources. Of course, CK-MB is not perfect, and troponin assays offer even higher specificity and sensitivity for myocardial injury, but among these two tests, CK-MB mass provides greater specificity for cardiac damage because it targets the relevant isoenzyme rather than the total enzyme activity originating from multiple tissues.

More practice questions